Perrigo Cash Flow Statement
PRGO / Health Care|14 years of annual SEC 10-K data (FY2012-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 14 fiscal years. All figures from audited SEC 10-K filings.
Perrigo generated $239M in operating cash flow and $145M in free cash flow in FY2025. Free cash flow margin was 3.4% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.4B | -$171.8M | -$12.7M | -$162.6M | $146.1M | -$162.6M | $119.6M | -$4.0B | $119.6M | -$4.0B | $136.1M | $180.6M | $232.8M | $401.6M |
| Depreciation & Amortization | $337.5M | $325.9M | $359.5M | $384.8M | $396.5M | $384.8M | $444.8M | $457.0M | $444.8M | $457.0M | $258.7M | $358.9M | $206.1M | $135.3M |
| Operating Cash Flow | $238.5M | $362.9M | $405.5M | $636.2M | $387.8M | $636.2M | $698.9M | $654.9M | $698.9M | $654.9M | $855.2M | $693.5M | $633.0M | $513.4M |
| Capital Expenditures | $93.4M | $118.3M | $101.7M | $170.4M | $137.7M | $170.4M | $88.6M | $106.2M | $88.6M | $106.2M | $137.0M | $171.6M | $171.6M | $120.2M |
| Free Cash Flow | $145.1M | $244.6M | $303.8M | $465.8M | $250.1M | $465.8M | $610.3M | $548.7M | $610.3M | $548.7M | $718.2M | $521.9M | $461.4M | $393.2M |
| Share Buybacks | - | - | - | $164.2M | $0 | $164.2M | $191.5M | $0 | $191.5M | $0 | $0 | $0 | $0 | $8.2M |
| Dividends Paid | $159.3M | $152.5M | $149.7M | $123.9M | $112.4M | $123.9M | $91.1M | $83.2M | $91.1M | $83.2M | $64.8M | $46.1M | $46.1M | $29.0M |
| FCF Margin | 3.4% | 5.6% | 6.5% | 11.4% | 6.5% | 11.4% | 12.3% | 10.4% | 12.3% | 10.4% | 17.0% | 28.3% | 11.8% | 12.4% |